The Tongtian river Bioeconomy Industrial Park (Pharmaceutical Health Industry Cluster), which is invested and operated by Hebei Sinobioway Biotech Co., Ltd., covers an area of 2,300 mu and has a planned total construction area of 2 million square meters, of which 1 million square meters are for production use. The area of the laboratory is 300,000 square meters, the residential area is 20 square meters, and other supporting facilities are 500,000 square meters. To build the world's largest drug production base that includes biological medicines, medical devices, modern Chinese medicine, and health foods. At the same time, construction of bio-economic incubators, authentic medicinal material quality inspection and appraisal centers, market trading centers, traditional Chinese medicine cultural tourism centers and other ancillary facilities will provide personalized, all-round, and nanny-style services for multi-personal talent innovation and entrepreneurship. The industrial park will play an important role in researching the implementation of medicine and food homology, boosting the research and development of new drugs, strengthening the standardiza-tion of traditional Chinese medicines, and upgrading the industrialization level of traditional Chinese medicine. By 2030, a batch of production lines of pharmaceutical product and health food will put into operation, with an annual output value of more than 100 billion yuan, and gain taxes of 20 billion yuan, it can provide 10,000 employ-ment positions, will create a 100 billion-level biomedicine health industry group, contribute to successfully tackle the health problem in China, achieve a healthy and strong nation.
By implementing the sGAP online quality testing plans of the planting of crude Chinese drugs, Sinobioway Group has built a tractable system of geo-authentic crude drugs in an effort to promote the establishment of a national testing center and integrate TCM resources to build a top TCM drug brand. In the mean time, by taking advantage of the Group’s unique strength, the company plans to build in the form of alliance 100 planting bases of over 500 most common varieties to become the largest producer and supplier of geo-authentic crude drugs.